Ross Douglas T. - 21 Dec 2022 Form 4 Insider Report for Oncocyte Corp (OCX)

Role
Former CSO
Signature
/s/ Douglas Ross
Issuer symbol
OCX
Transactions as of
21 Dec 2022
Net transactions value
$0
Form type
4
Filing time
22 Dec 2022, 17:57:14 UTC
Previous filing
20 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCX Common Stock, no par value Award $0 +213,797 +1052% $0.000000 234,114 21 Dec 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units will vest as follows: (i) one-third on January 31, 2023, (ii) one-third on February 28, 2023, and (ii) one-third on March 31, 2023 (each such date, a "Vesting Date"), in each case, subject to the Reporting Person's continuous service as a consultant on each applicable Vesting Date.